USPRX yields 4.41% · MRK yields 3.25%● Live data
📍 MRK pulled ahead of the other in Year 1
Combined, USPRX + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of USPRX + MRK for your $10,000?
The fund's principal investment strategy is, under normal market conditions, to invest at least 80% of the fund's assets in the common stocks of companies composing the index. In seeking to track the performance of the index, the fund's subadviser attempts to allocate the fund's investments among stocks in approximately the same weightings as the index, beginning with the stocks that make up the larger portion of the index's value.
Full USPRX Calculator →Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.